AI cannot be an inventor rules USPTO, IPO extends SIPP Scheme and other patent news

The USPTO has ruled that AI cannot be named as a patent inventor, aligning with recent decisions by UKIPO and EPO. The Indian Patent Office has extended the SIPP Scheme, while CSIR allows deferred payments for COVID-19 related IP. Key updates also include Gilead’s global access strategy for Remdesivir and new developments from IPOS Singapore and USTR.

Read more about AI cannot be an inventor rules USPTO, IPO extends SIPP Scheme and other patent news

Partial activity resumes at IPO amidst extended national lockdown

The Indian Patent Office has resumed partial operations amid the extended national lockdown, resulting in a marked increase in patent publications, grants, and design registrations. This update provides an objective overview of key statistics and city-wise contributions to intellectual property filings.

Read more about Partial activity resumes at IPO amidst extended national lockdown

Royalty free IP license to fight COVID-19 pandemic, Patent Agent Examination registrations extended and more

The post examines key IP updates related to COVID-19, including the Indian Patent Office’s procedural changes and Ireland’s royalty free IP license initiative. It highlights efforts to promote collaborative innovation during the pandemic through flexible licensing and policy measures.

Read more about Royalty free IP license to fight COVID-19 pandemic, Patent Agent Examination registrations extended and more

Dr. Kalyan Kankanala delivers a talk on Infringement Analysis for students at NLSIU – Bangalore on April 19th , 2020

Dr. Kalyan explained the concept of patent infringement, assessing literal infringement and infringement by doctrine of equivalence with examples. The infringement test used in the...

Read more about Dr. Kalyan Kankanala delivers a talk on Infringement Analysis for students at NLSIU – Bangalore on April 19th , 2020